by
Adam Samuels
"We’re
enthused about stocks," says Ken Crawford, portfolio manager
for Argent Capital Management. This sentiment echoes the tone
of the last six months of Portfolio. "Third quarter earnings
were strong across the board, and, because growth is accelerating,
we think 2004 will be strong-not as strong as 03, perhaps, but
strong." Crawford thinks this is due to the continued strength
in the Asian economies, including Japan, which is recovering,
and China, which continues to be, as he puts it, "a juggernaut."
With Europe and Latin America also improving, he does not think
the Federal Reserve will choke off recovery because inflation
seems to be in check.
For
bondholders, Crawford’s advice is to "stay with short
maturities because we’re worried that at some point Greenspan
will raise rates.We’ve seen bond prices falling this year
and investors have seen that those prices do fall as well as rise.
Hold bonds as a store of value instead of a speculative investment."
Along those lines, Crawford reiterated what we have heard at least
since July of this year: equities are not overvalued and offer
greater reward relative to fixed income.
Turning
to Portfolio, Crawford knew exactly what he wanted to do to fix
it. The first addition he made was J. C. Penney. (JCP). His reasoning
is that, number one, "its core department store profits are
improving and we think it has room to continue for the next couple
of years. Secondarily, they own the Eckerd’s Drug Store
chain, which has been woeful." Because JCP’s management
has committed to doing something with the chain by year’s
end, Crawford is hopeful that means it will sell it to reduce
debt and buy back shares.This stock is an intriguing pick, then,
as department store chains struggle with their unwieldy format.What
is this company doing that seems to have eluded others? Crawford
believes it’s a "three pronged approach. Penney’s
has the department stores, online business, and the J.C. Penney
catalog, the only retailer with this thrust." The message
is that if it’s not here, we’ll get it for you. With
improvement as a fashion entity and cost saving measures including
eliminating regional buying offices and non-performing units,
Crawford’s feels this is a great addition to Portfolio.
The
second addition to Portfolio is Novellus (NVLS), a semi-conductor
equipment company which makes the machines that make the chips
for Intel. "It’s a play on economic recovery because
more semiconductors are used as capacity utilization increases,"
says Crawford. With orders improving by 25 percent this quarter,
which was greater than expected, and Novellus’ being on
the leading edge of technology, this is a new cyclical name which
should benefit from a strong economy.
To
make room for these new names, two must now be removed. Crawford’s
first choice for elimination is Royal Dutch—for two reasons.
The first one is that in a portfolio of 10 stocks, we’ve
got three energy names. Hmm. I guess he’s right. "With
oil at $30 per barrel and gas at $5 per MCF, that is historically
very high," he says, adding, "If you believe in any
normalization, energy is going to fall." The second stock
we’re removing is Cardinal Health, primarily because Merck
(MRK) is no longer going to allow inventory pre-buys from direct
distributors in front of price increases. Because that is half
of Cardinal’s profits, Crawford feels it should be removed.

BACK
TO NETWORK HOME